期刊
NATURE CELL BIOLOGY
卷 23, 期 7, 页码 682-683出版社
NATURE PORTFOLIO
DOI: 10.1038/s41556-021-00712-y
关键词
-
类别
A new study has shown that the SARS-CoV-2 nucleocapsid protein can suppress the antiviral response by directly interacting with the signalling adaptor protein MAVS. Targeting this pathway could be a promising therapeutic strategy to enhance immunity against COVID-19.
A new study shows that the SARS-CoV-2 nucleocapsid protein represses the antiviral type I interferon response through direct interaction with the signalling adaptor protein MAVS. Targeting this process might be a useful therapeutic strategy to boost immunity against COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据